Jordi Xaus

Chief Tech/Sci/R&D Officer presso ORYZON GENOMICS S.A.

Health Technology

Consumer Services

Profilo

Jordi Xaus is currently the Chief Scientific Officer at Oryzon Genomics SA since 2021.
Previously, he worked as the Director & Biomedicine Director at Biosearch SA. He also served as an Associate Professor at the University of Barcelona from 2000 to 2001.
Additionally, he held the position of Chief Scientific Officer at Palau Pharma SA. Dr. Xaus obtained a doctorate degree from the University of Barcelona in 1994, followed by a graduate degree in 1997.
He later earned another graduate degree from Ramon Llull University in 2009.

Posizioni attive di Jordi Xaus

Società	Posizione	Inizio
ORYZON GENOMICS S.A.	Chief Tech/Sci/R&D Officer	01/07/2021

Tutte le posizioni attive di Jordi Xaus

Precedenti posizioni note di Jordi Xaus

Società	Posizione	Fine
University of Barcelona	Corporate Officer/Principal	01/01/2001
BIOSEARCH, S.A.	Director/Board Member	-
Palau Pharma SA Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain.	Chief Tech/Sci/R&D Officer	-

Vedi nel dettaglio l'esperienza di Jordi Xaus

Formazione di Jordi Xaus

University of Barcelona	Doctorate Degree
Ramon Llull University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jordi Xaus

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ORYZON GENOMICS S.A.	Health Technology

Aziende private	2
Biosearch SA Biosearch SA Pharmaceuticals: OtherHealth Technology Biosearch SA engages in the provision of products for pharmaceutical, nutritional, and functional food sectors. It develops and markets three product platforms including Omega-3, Probiotics and Botanical Extracts. The company was founded on September 12, 2000 and is headquartered in Granada, Spain.	Health Technology
Palau Pharma SA Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain.	Health Technology